Host variations in SARS-CoV-2 infection

Autor: Savcı, E. Z., Özkara, B., Alkan, K., Namdar, D. S., Tunçer, G., Kılınç, B. R., Suiçmez, E., Ünal, S., Dönmüş, B., Karagülleoğlu, Z. Y., Uncuoğlu, D. B., Tekeli, C., Mendi, A. H., Bengi, V. U., Seval, G. C., Kılıç, P., Altuntaş, E. G., Dora, D. D., Çetin, Güneysu, Altıok, D.

Publikováno v: Turkish Journal of Biology

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the zoonotic pathogen that causes the “Coronavirus Disease of 2019 (COVID-19)”, and COVID-19 itself is yet to be thoroughly understood. Both the disease as well as the mechan

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3533::5d9eeaef9fc99e3b428cca66acef3668
https://hdl.handle.net/11693/77241

Impacts of timing, length, and intensity of behavioral interventions to COVID-19 dynamics: North Carolina countylevel examples.

Autor: Quiner, Claire¹ cquiner@rti.org, Jones, Kasey¹, Bobashev, Georgiy¹

Publikováno v: Infectious Disease Modelling (2468-2152). Sep2022, Vol. 7 Issue 3, p535-544. 10p.

RNA barcode segments for SARS-CoV-2 identification from HCoVs and SARSr-CoV-2 lineages.

Autor: Changqiao You, Shuai Jiang, Yunyun Ding, Shunxing Ye, Xiaoxiao Zou, Hongming Zhang, Zeqi Li, Fenglin Chen, Yongliang Li, Xingyi Ge, Xinhong Guo

Publikováno v: Virologica Sinica (16740769); Feb2024, Vol. 39 Issue 1, p156-168, 13p

Luteolin inhibits spike protein of severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) binding to angiotensin‐converting enzyme 2.

Autor: Zhu, Junjie, Yan, Huimin, Shi, Mengyao, Zhang, Min, Lu, Jia, Wang, Jiabao, Chen, Lu, Wang, Yu, Li, Lin, Miao, Lin, Zhang, Han

Publikováno v: Phytotherapy Research; Aug2023, Vol. 37 Issue 8, p3508-3521, 14p

The clinical progress and challenges of mRNA vaccines.

Autor: Yu MZ; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology (NCNST), Beijing, People's Republic of China.; University of Chinese Academy of Sciences (UCAS), Beijing, People's Republic of China., Wang NN; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology (NCNST), Beijing, People's Republic of China.; University of Chinese Academy of Sciences (UCAS), Beijing, People's Republic of China., Zhu JQ; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology (NCNST), Beijing, People's Republic of China., Lin YX; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology (NCNST), Beijing, People's Republic of China.; University of Chinese Academy of Sciences (UCAS), Beijing, People's Republic of China.

Publikováno v: Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology [Wiley Interdiscip Rev Nanomed Nanobiotechnol] 2023 Sep-Oct; Vol. 15 (5), pp. e1894. Date of Electronic Publication: 2023 Apr 24.